These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 6794884)

  • 1. The glycosphingolipids of human plasma lipoproteins.
    Clarke JT
    Can J Biochem; 1981 Jun; 59(6):412-7. PubMed ID: 6794884
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Distribution of glycosphingolipids in the serum lipoproteins of normal human subjects and patients with hypo- and hyperlipidemias.
    Dawson G; Kruski AW; Scanu AM
    J Lipid Res; 1976 Mar; 17(2):125-31. PubMed ID: 178813
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neutral glycosphingolipids of serum lipoproteins in Fabry's disease.
    Clarke JT; Stoltz JM; Mulcahey MR
    Biochim Biophys Acta; 1976 May; 431(2):317-25. PubMed ID: 181056
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An improved technique for separation of neutral glycosphingolipids by high-performance liquid chromatography.
    Suzuki A; Kundu SK; Marcus DM
    J Lipid Res; 1980 May; 21(4):473-7. PubMed ID: 6892925
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Blood glucosylceramide levels in Gaucher's disease and its distribution amongst lipoprotein fractions.
    Dawson G; Oh JY
    Clin Chim Acta; 1977 Feb; 75(1):149-53. PubMed ID: 844195
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of serum lipoproteins in the pathogenesis of Gaucher disease.
    Dawson G; Kwok BC; Nishigaki M; Shen BW
    Prog Clin Biol Res; 1982; 95():253-65. PubMed ID: 7122636
    [No Abstract]   [Full Text] [Related]  

  • 7. Localization of neutral glycosphingolipids in human plasma.
    van den Bergh FA; Tager JM
    Biochim Biophys Acta; 1976 Sep; 441(3):391-402. PubMed ID: 184824
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stability of plasma low density lipoprotein with abnormal glycolipid composition from patients with Fabry's disease.
    Clarke JT; Stoltz JM; Garner JB
    Atherosclerosis; 1980 Feb; 35(2):155-63. PubMed ID: 6766308
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Global glycosphingolipid analysis in urine and plasma of female Fabry disease patients.
    Heywood WE; Doykov I; Spiewak J; Hallqvist J; Mills K; Nowak A
    Biochim Biophys Acta Mol Basis Dis; 2019 Oct; 1865(10):2726-2735. PubMed ID: 31319156
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Thin-layer chromatography of neutral glycosphingolipids: an improved simple method for the resolution of GlcCer, GalCer, LacCer and Ga2Cer.
    Ogawa K; Fujiwara Y; Sugamata K; Abe T
    J Chromatogr; 1988 Apr; 426(1):188-93. PubMed ID: 3133382
    [No Abstract]   [Full Text] [Related]  

  • 11. Reduced plasma concentrations of total, low density lipoprotein and high density lipoprotein cholesterol in patients with Gaucher type I disease.
    Ginsberg H; Grabowski GA; Gibson JC; Fagerstrom R; Goldblatt J; Gilbert HS; Desnick RJ
    Clin Genet; 1984 Aug; 26(2):109-16. PubMed ID: 6432380
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Blood group type glycosphingolipids of human cord blood erythrocytes.
    Larson G; Samuelsson BE
    J Biochem; 1980 Sep; 88(3):647-57. PubMed ID: 7419515
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neutral glycosphingolipids of the globo-series characterize activation stages corresponding to germinal center B cells.
    Schwartz-Albiez R; Dörken B; Möller P; Brodin NT; Monner DA; Kniep B
    Int Immunol; 1990; 2(10):929-36. PubMed ID: 2078521
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structures and fatty acid compositions of neutral glycosphingolipids of human plasma.
    Kościelak J; Maśliński W; Zieleński J; Zdebska E; Brudzyński T; Miller-Podraza H; Cedergren B
    Biochim Biophys Acta; 1978 Sep; 530(3):385-93. PubMed ID: 698239
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Occurrence of sulfatide as a major glycosphingolipid in WHHL rabbit serum lipoproteins.
    Hara A; Taketomi T
    J Biochem; 1987 Jul; 102(1):83-92. PubMed ID: 3667567
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasma exchange removes glycosphingolipid in Fabry disease.
    Pyeritz RE; Ullman MD; Moser AB; Braine HG; Moser HW
    Am J Med Genet; 1980; 7(3):301-7. PubMed ID: 6781344
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neutral glycosphingolipids in human blood: a precise mass spectrometry analysis with special reference to lipoprotein-associated Shiga toxin receptors.
    Schweppe CH; Hoffmann P; Nofer JR; Pohlentz G; Mormann M; Karch H; Friedrich AW; Müthing J
    J Lipid Res; 2010 Aug; 51(8):2282-94. PubMed ID: 20444989
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glycosphingolipids and plasma lipoproteins: a review.
    Chatterjee S; Kwiterovich PO
    Can J Biochem Cell Biol; 1984 Jun; 62(6):385-97. PubMed ID: 6088014
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mass spectrometric quantification of plasma glycosphingolipids in human GM3 ganglioside deficiency.
    Aoki K; Heaps AD; Strauss KA; Tiemeyer M
    Clin Mass Spectrom; 2019 Nov; 14 Pt B():106-114. PubMed ID: 34917767
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Normalizing glycosphingolipids restores function in CD4+ T cells from lupus patients.
    McDonald G; Deepak S; Miguel L; Hall CJ; Isenberg DA; Magee AI; Butters T; Jury EC
    J Clin Invest; 2014 Feb; 124(2):712-24. PubMed ID: 24463447
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.